<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>HM-Listed — Portfolio on 6ix</title>
<link>https://6ix.com/p/hm-listed</link>
<description>Top companies trading on HM, ranked by market cap.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 15:46:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/portfolio/hm-listed" rel="self" type="application/rss+xml" />
<item>
<title>Texas Instruments Incorporated: Texas Instruments launches the TI-84 Evo Graphing Calculator -- the most advanced TI-84 ever built</title>
<link>https://6ix.com/company/texas-instruments-incorporated/news/texas-instruments-launches-the-ti-84-evo-graphing-calculator-the-most-advanced-ti-84-ever-built</link>
<guid isPermaLink="true">https://6ix.com/company/texas-instruments-incorporated/news/texas-instruments-launches-the-ti-84-evo-graphing-calculator-the-most-advanced-ti-84-ever-built</guid>
<pubDate>Tue, 28 Apr 2026 15:46:00 GMT</pubDate>
<description>Texas Instruments Education Technology (TI), a division of the global semiconductor company, today announced the launch of the TI-84 Evo Graphing Calculator, the latest and most powerful addition to the TI-84 series. Featuring a 3x faster processor, 50% more graphing space, and a redesigned keypad, the TI-84 Evo is a deliberate evolution of a platform educators and students have relied on for decades, built to meet the demands of today's math classroom and grow with students from middle school a</description>
</item>
<item>
<title>Duke Energy Corporation: Duke Energy Foundation invests $275,000 in nonprofits supporting Floridians' most essential needs</title>
<link>https://6ix.com/company/duke-energy-corporation/news/duke-energy-foundation-invests-dollar275000-in-nonprofits-supporting-floridians-most-essential-needs</link>
<guid isPermaLink="true">https://6ix.com/company/duke-energy-corporation/news/duke-energy-foundation-invests-dollar275000-in-nonprofits-supporting-floridians-most-essential-needs</guid>
<pubDate>Tue, 28 Apr 2026 15:21:00 GMT</pubDate>
<description>The Duke Energy Foundation is awarding $275,000 to 15 nonprofit organizations that are helping meet Floridians' most basic, essential needs and increasing access to quality health care, affordable housing, workforce development and more.</description>
</item>
<item>
<title>Pfizer Inc: Pfizer Reaches Three Settlement Agreements for VYNDAMAX</title>
<link>https://6ix.com/company/pfizer-inc/news/pfizer-reaches-three-settlement-agreements-for-vyndamax</link>
<guid isPermaLink="true">https://6ix.com/company/pfizer-inc/news/pfizer-reaches-three-settlement-agreements-for-vyndamax</guid>
<pubDate>Tue, 28 Apr 2026 14:17:00 GMT</pubDate>
<description>NEW YORK, April 28, 2026--Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the U.S. District Court for the District of Delaware for infringement of patents relating to VYNDAMAX® (tafamidis), a treatment for cardiomyopathy transthyretin-mediated amyloidosis (ATTR-CM). These settlements extend the effective U.S. patent expiry date for VYNDAMAX to Jun</description>
</item>
<item>
<title>3m Company: Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031</title>
<link>https://6ix.com/company/3m-company/news/bulk-filtration-market-report-2026-competitive-analysis-of-3m-eaton-parker-hannifin-pentair-merck-danaher-mannhummel-analyst-recommendations-and-global-forecast-to-2031</link>
<guid isPermaLink="true">https://6ix.com/company/3m-company/news/bulk-filtration-market-report-2026-competitive-analysis-of-3m-eaton-parker-hannifin-pentair-merck-danaher-mannhummel-analyst-recommendations-and-global-forecast-to-2031</guid>
<pubDate>Tue, 28 Apr 2026 14:00:00 GMT</pubDate>
<description>Key market opportunities include growing demand for advanced filtration technologies driven by industrialization and stringent environmental regulations. Smart filtration systems with IoT and AI, self-cleaning technologies, and membrane filtration methods like ultrafiltration and reverse osmosis are becoming crucial for efficiency and sustainability.Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Bulk Filtration Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering.Th</description>
</item>
<item>
<title>Vertex Pharmaceuticals Inc: A Call to Action to Help Fight Kidney Failure in At-Risk Communities: American Kidney Fund Urges People to be APOL1 Aware</title>
<link>https://6ix.com/company/vertex-pharmaceuticals-inc/news/a-call-to-action-to-help-fight-kidney-failure-in-at-risk-communities-american-kidney-fund-urges-people-to-be-apol1-aware</link>
<guid isPermaLink="true">https://6ix.com/company/vertex-pharmaceuticals-inc/news/a-call-to-action-to-help-fight-kidney-failure-in-at-risk-communities-american-kidney-fund-urges-people-to-be-apol1-aware</guid>
<pubDate>Tue, 28 Apr 2026 13:02:00 GMT</pubDate>
<description>Newly established AMKD Coalition unites leading voices to address need to heighten awareness of APOL1-mediated kidney disease (AMKD)ROCKVILLE, Md., April 28, 2026 (GLOBE NEWSWIRE) -- Today marks the third annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day, a day established by the American Kidney Fund (AKF) to encourage others to be “APOL1 Aware” by educating communities about this genetic form of rapidly progressing kidney disease. Support for AMKD Awareness Day is provided by Vertex Pha</description>
</item>
<item>
<title>Abbott Laboratories: Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform</title>
<link>https://6ix.com/company/abbott-laboratories/news/abbott-receives-fda-clearance-and-ce-mark-for-next-generation-ultreontm-30-ai-powered-coronary-imaging-platform</link>
<guid isPermaLink="true">https://6ix.com/company/abbott-laboratories/news/abbott-receives-fda-clearance-and-ce-mark-for-next-generation-ultreontm-30-ai-powered-coronary-imaging-platform</guid>
<pubDate>Tue, 28 Apr 2026 13:00:00 GMT</pubDate>
<description>Abbott (NYSE: ABT) today announced it received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next-generation Ultreon™ 3.0 Software. This marks a major step forward as it brings coronary imaging and AI-automated insights together in one system to support better patient outcomes and help reduce risks.</description>
</item>
<item>
<title>Oracle Corporation: NetSuite Brings AI-Powered Speed and Precision to SuiteCloud Development</title>
<link>https://6ix.com/company/oracle-corporation/news/netsuite-brings-ai-powered-speed-and-precision-to-suitecloud-development</link>
<guid isPermaLink="true">https://6ix.com/company/oracle-corporation/news/netsuite-brings-ai-powered-speed-and-precision-to-suitecloud-development</guid>
<pubDate>Tue, 28 Apr 2026 13:00:00 GMT</pubDate>
<description>SuiteConnect San Francisco -- Oracle NetSuite, the #1 AI cloud ERP, today announced new NetSuite knowledge packages for AI coding agents that will help customers and partners accelerate and de-risk the creation of NetSuite applications and customizations. The new NetSuite SuiteCloud Agent Skills will make it easier for developers to create customized vertical and industry-specific applications by giving AI coding assistants a better understanding of the conventions, patterns, and best practices</description>
</item>
<item>
<title>Hershey Co: Ryl Tea Debuts Zero-Sugar Iced Teas Inspired by Iconic Jolly Rancher Candy Flavors</title>
<link>https://6ix.com/company/hershey-co/news/ryl-tea-debuts-zero-sugar-iced-teas-inspired-by-iconic-jolly-rancher-candy-flavors</link>
<guid isPermaLink="true">https://6ix.com/company/hershey-co/news/ryl-tea-debuts-zero-sugar-iced-teas-inspired-by-iconic-jolly-rancher-candy-flavors</guid>
<pubDate>Tue, 28 Apr 2026 12:55:00 GMT</pubDate>
<description>Ryl Tea, a fast-growing ready-to-drink beverage brand, is teaming up with The Hershey Company to bring Jolly RancherCandy's iconic fruit flavors into iced tea for the first time. The new lineup, available in Blue Raspberry, Green Apple and Cherry, reimagines the bold candy flavors fans know and love as refreshing, zero-sugar iced teas made for everyday drinking.</description>
</item>
<item>
<title>Gilead Sciences Inc: Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel</title>
<link>https://6ix.com/company/gilead-sciences-inc/news/gilead-sciences-completes-acquisition-of-arcellx-ahead-of-potential-commercial-launch-of-anito-cel</link>
<guid isPermaLink="true">https://6ix.com/company/gilead-sciences-inc/news/gilead-sciences-completes-acquisition-of-arcellx-ahead-of-potential-commercial-launch-of-anito-cel</guid>
<pubDate>Tue, 28 Apr 2026 12:45:00 GMT</pubDate>
<description>FOSTER CITY, Calif., April 28, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX). Under the terms of the transaction, Gilead acquired Arcellx for $115 per share in cash, plus one non‑transferable contingent value right (CVR) of $5 per share, representing a total implied equity value of approximately $7.8 billion at the time of closing.</description>
</item>
<item>
<title>Meta Platforms Inc.: NIL Club Announces Meta Activation of Nationwide Student-Athlete Campaign for Ray-Ban Meta Smart Glasses</title>
<link>https://6ix.com/company/meta-platforms-inc/news/nil-club-announces-meta-activation-of-nationwide-student-athlete-campaign-for-ray-ban-meta-smart-glasses</link>
<guid isPermaLink="true">https://6ix.com/company/meta-platforms-inc/news/nil-club-announces-meta-activation-of-nationwide-student-athlete-campaign-for-ray-ban-meta-smart-glasses</guid>
<pubDate>Tue, 28 Apr 2026 12:43:00 GMT</pubDate>
<description>NIL Club, the leading platform connecting brands with college athletes through team-based communities, today announced that Meta is leveraging its platform to activate hundreds of student-athletes nationwide in support of the Ray-Ban Meta smart glasses campaign.</description>
</item>
<item>
<title>Relx Plc: RELX Group enters into agreement to acquire French Legaltech company Doctrine</title>
<link>https://6ix.com/company/relx-plc/news/relx-group-enters-into-agreement-to-acquire-french-legaltech-company-doctrine</link>
<guid isPermaLink="true">https://6ix.com/company/relx-plc/news/relx-group-enters-into-agreement-to-acquire-french-legaltech-company-doctrine</guid>
<pubDate>Tue, 28 Apr 2026 12:20:00 GMT</pubDate>
<description>RELX Group is planning to acquire Doctrine, strengthening authoritative legal AI workflows in France and across Europe.Paris, France / New York, NY, April 28, 2026 (GLOBE NEWSWIRE) -- RELX Group, which owns LexisNexis® Legal & Professional, a global leader in information, analytics, and AI-powered legal workflow solutions, today announced it has offered to acquire Doctrine, France-based Legal AI platform recognized for its advanced AI tools in legal search, analysis, drafting and practitioner wo</description>
</item>
<item>
<title>Intuitive Surgical Inc: Medical Robotics Market Size to Grow USD 102.75 Billion by 2035 | Research by SNS Insider</title>
<link>https://6ix.com/company/intuitive-surgical-inc/news/medical-robotics-market-size-to-grow-usd-10275-billion-by-2035-or-research-by-sns-insider</link>
<guid isPermaLink="true">https://6ix.com/company/intuitive-surgical-inc/news/medical-robotics-market-size-to-grow-usd-10275-billion-by-2035-or-research-by-sns-insider</guid>
<pubDate>Tue, 28 Apr 2026 12:10:00 GMT</pubDate>
<description>The United States medical robotics market was estimated to be worth USD 9.87 billion in 2025 and is projected to increase at 16.00% CAGR from 2026 to 2035, reaching USD 43.16 billion. With the greatest number of robotic surgical system installations, well-known clinical research initiatives, and the global headquarters of many industry leaders, such as Intuitive Surgical, Stryker, Medtronic, and Zimmer Biomet, the U.S. is the largest medical robotics market in the world.Austin, April 28, 2026 (G</description>
</item>
<item>
<title>Apple Inc: Ramsey Theory Group CEO Dan Herbatschek Warns Wall Street’s AI Boom Faces an ROI Reckoning as Big Tech Earnings Week Begins</title>
<link>https://6ix.com/company/apple-inc/news/ramsey-theory-group-ceo-dan-herbatschek-warns-wall-streets-ai-boom-faces-an-roi-reckoning-as-big-tech-earnings-week-begins</link>
<guid isPermaLink="true">https://6ix.com/company/apple-inc/news/ramsey-theory-group-ceo-dan-herbatschek-warns-wall-streets-ai-boom-faces-an-roi-reckoning-as-big-tech-earnings-week-begins</guid>
<pubDate>Tue, 28 Apr 2026 11:45:00 GMT</pubDate>
<description>With Microsoft, Meta, Amazon, Alphabet and Apple reporting results, Herbatschek says the next phase of the AI market will reward measurable outcomes and not unchecked spendingNEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence has become the defining investment story on Wall Street, powering surging valuations, record infrastructure spending, and an escalating arms race among the world’s largest technology companies. But according to Dan Herbatschek, CEO of Ramsey Theory Group,</description>
</item>
<item>
<title>Microsoft Corporation: GitHub Copilot Dev Days Comes to Florida - One Event, One City, One Chance</title>
<link>https://6ix.com/company/microsoft-corporation/news/github-copilot-dev-days-comes-to-florida-one-event-one-city-one-chance</link>
<guid isPermaLink="true">https://6ix.com/company/microsoft-corporation/news/github-copilot-dev-days-comes-to-florida-one-event-one-city-one-chance</guid>
<pubDate>Tue, 28 Apr 2026 11:15:00 GMT</pubDate>
<description>NLP Logix is sponsoring Florida's only GitHub Copilot Dev Days gathering, a free, in-person event designed to showcase how AI-assisted coding is transforming modern software development. Taking place on May 7th from 5:30 PM to 8:30 PM at the link in Nocatee, FL, the event is part of a global series highlighting how GitHub Copilot helps streamline real-world workflows, from writing code to deployment, while enabling teams to work more efficiently.</description>
</item>
<item>
<title>Microchip Technology Inc: Microchip Expands its Family of Post-Quantum‑Ready Root of Trust Controllers for Next‑Generation Systems</title>
<link>https://6ix.com/company/microchip-technology-inc/news/microchip-expands-its-family-of-post-quantumready-root-of-trust-controllers-for-nextgeneration-systems</link>
<guid isPermaLink="true">https://6ix.com/company/microchip-technology-inc/news/microchip-expands-its-family-of-post-quantumready-root-of-trust-controllers-for-nextgeneration-systems</guid>
<pubDate>Tue, 28 Apr 2026 11:12:00 GMT</pubDate>
<description>Platform Root of Trust and secure boot controllers help system architects prepare for emerging mandates across data center and infrastructure platformsCHANDLER, Ariz., April 28, 2026 (GLOBE NEWSWIRE) -- CHANDLER, Ariz., April 28, 2026 — As the industry embarks on the transition to post‑quantum cryptography (PQC), Microchip Technology (Nasdaq: MCHP) is expanding its portfolio of Trust Shield, PQC‑ready devices with the TS1800 Platform Root of Trust controller and the TS50x secure boot controller.</description>
</item>
<item>
<title>Corning Incorporated: Corning Announces Strong First-Quarter 2026 Financial Results (1)</title>
<link>https://6ix.com/company/corning-incorporated/news/corning-announces-strong-first-quarter-2026-financial-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/corning-incorporated/news/corning-announces-strong-first-quarter-2026-financial-results-1</guid>
<pubDate>Tue, 28 Apr 2026 11:01:00 GMT</pubDate>
<description>CORNING, N.Y., April 28, 2026--Corning Incorporated (NYSE: GLW) today announced its first-quarter 2026 results and provided its outlook for second-quarter 2026.</description>
</item>
<item>
<title>Astrazeneca Plc: BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older</title>
<link>https://6ix.com/company/astrazeneca-plc/news/breztri-approved-in-the-us-for-asthma-as-first-and-only-triple-therapy-for-patients-12-years-of-age-and-older</link>
<guid isPermaLink="true">https://6ix.com/company/astrazeneca-plc/news/breztri-approved-in-the-us-for-asthma-as-first-and-only-triple-therapy-for-patients-12-years-of-age-and-older</guid>
<pubDate>Tue, 28 Apr 2026 11:00:00 GMT</pubDate>
<description>WILMINGTON, Del., April 28, 2026--AstraZeneca’s fixed-dose triple-combination therapy BREZTRI Aerosphere® (budesonide/glycopyrrolate/formoterol fumarate or BGF 320/36/9.6μg) has been approved in the US for the maintenance treatment of asthma in adult and pediatric patients 12 years of age and older. BREZTRI is a single-inhaler that combines the efficacy of corticosteroid/long-acting beta2-agonist (ICS/LABA) medicines with a long-acting muscarinic antagonist (LAMA). BREZTRI (320/18/9.6μg) was app</description>
</item>
<item>
<title>The Coca-cola Company: Coca-Cola Reports First Quarter 2026 Results and Updates Full Year Guidance</title>
<link>https://6ix.com/company/the-coca-cola-company/news/coca-cola-reports-first-quarter-2026-results-and-updates-full-year-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/the-coca-cola-company/news/coca-cola-reports-first-quarter-2026-results-and-updates-full-year-guidance</guid>
<pubDate>Tue, 28 Apr 2026 10:55:00 GMT</pubDate>
<description>ATLANTA, April 28, 2026--The Coca-Cola Company today reported first quarter 2026 results. "We’ve had a strong start to the year," said Henrique Braun, CEO of The Coca-Cola Company. "Our performance this quarter reflects our unwavering focus on staying close to the consumer, executing locally and managing complexity. Yet there’s so much more we can do as we navigate a dynamic environment. Our team is motivated by the opportunity to build on the company’s great foundation."</description>
</item>
<item>
<title>Merck & Company Inc: Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called "Bad" Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke</title>
<link>https://6ix.com/company/merck-and-company-inc/news/mercks-playing-with-heart-program-teams-up-with-professional-baseball-clubs-and-baseball-legends-to-help-raise-awareness-about-ldl-c-called-bad-cholesterol-and-how-it-may-impact-the-risk-of-heart-attack-or-stroke</link>
<guid isPermaLink="true">https://6ix.com/company/merck-and-company-inc/news/mercks-playing-with-heart-program-teams-up-with-professional-baseball-clubs-and-baseball-legends-to-help-raise-awareness-about-ldl-c-called-bad-cholesterol-and-how-it-may-impact-the-risk-of-heart-attack-or-stroke</guid>
<pubDate>Tue, 28 Apr 2026 10:45:00 GMT</pubDate>
<description>RAHWAY, N.J., April 28, 2026--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a collaboration with nine professional baseball teams and former professional baseball players to launch the Playing with Heart educational program to help educate adults about the importance of knowing their low-density lipoprotein cholesterol (LDL-C), called "bad" cholesterol, number and the potential increased risk of heart attack or stroke.</description>
</item>
<item>
<title>Verizon Communications Inc: *MEDIA ALERT* How to win free tickets to the FIFA World Cup 2026™ Final with Verizon</title>
<link>https://6ix.com/company/verizon-communications-inc/news/media-alert-how-to-win-free-tickets-to-the-fifa-world-cup-2026tm-final-with-verizon</link>
<guid isPermaLink="true">https://6ix.com/company/verizon-communications-inc/news/media-alert-how-to-win-free-tickets-to-the-fifa-world-cup-2026tm-final-with-verizon</guid>
<pubDate>Tue, 28 Apr 2026 10:00:00 GMT</pubDate>
<description>NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Verizon is giving its mobile and home customers, as well as small businesses nationwide, the ultimate chance to experience the FIFA World Cup 2026™ Final. As the excitement builds this spring, Verizon continues to bring fans closer to the action than anyone else. FIFA World Cup 2026™ Final Ticket Drop via Verizon Access: The prize: Tickets to the FIFA World Cup 2026™ Final at the New York New Jersey Stadium on July 19. Please note that travel and acco</description>
</item>
<item>
<title>United Parcel Service Inc: UPS Releases 1Q 2026 Earnings</title>
<link>https://6ix.com/company/united-parcel-service-inc/news/ups-releases-1q-2026-earnings</link>
<guid isPermaLink="true">https://6ix.com/company/united-parcel-service-inc/news/ups-releases-1q-2026-earnings</guid>
<pubDate>Tue, 28 Apr 2026 10:00:00 GMT</pubDate>
<description>ATLANTA, April 28, 2026--UPS (NYSE:UPS) today announced first-quarter 2026 consolidated revenues of $21.2 billion. Consolidated operating profit was $1.27 billion; non-GAAP adjusted consolidated operating profit was $1.32 billion. Diluted earnings per share were $1.02 for the quarter; non-GAAP adjusted diluted earnings per share were $1.07.</description>
</item>
<item>
<title>Merck & Company Inc: Gastroesophageal Adenocarcinoma Market Research Report 2026, Competitive Analysis of ALX Oncology, Merck, AstraZeneca, BeOne Medicines, Taiho Pharmaceuticals, Eli Lilly - Global Forecast to 2035</title>
<link>https://6ix.com/company/merck-and-company-inc/news/gastroesophageal-adenocarcinoma-market-research-report-2026-competitive-analysis-of-alx-oncology-merck-astrazeneca-beone-medicines-taiho-pharmaceuticals-eli-lilly-global-forecast-to-2035</link>
<guid isPermaLink="true">https://6ix.com/company/merck-and-company-inc/news/gastroesophageal-adenocarcinoma-market-research-report-2026-competitive-analysis-of-alx-oncology-merck-astrazeneca-beone-medicines-taiho-pharmaceuticals-eli-lilly-global-forecast-to-2035</guid>
<pubDate>Tue, 28 Apr 2026 08:02:00 GMT</pubDate>
<description>Gastroesophageal adenocarcinoma (GEA), a cancer prevalent in the esophagus' glandular cells or stomach's gastroesophageal junction, is on the rise due to risk factors like GERD, obesity, and smoking. This aggressive cancer is often diagnosed at advanced stages, complicating treatment and worsening prognosis. Market growth is driven by the aging population and lifestyle-related risks, boosting demand for diagnostics and therapies. Leading companies like Merck and AstraZeneca are advancing GEA tre</description>
</item>
<item>
<title>Stmicroelectronics N.v.: STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors</title>
<link>https://6ix.com/company/stmicroelectronics-nv/news/stmicroelectronics-brings-always-on-vision-to-next-generation-personal-electronics-with-new-ultralow-power-image-sensors</link>
<guid isPermaLink="true">https://6ix.com/company/stmicroelectronics-nv/news/stmicroelectronics-brings-always-on-vision-to-next-generation-personal-electronics-with-new-ultralow-power-image-sensors</guid>
<pubDate>Tue, 28 Apr 2026 06:00:00 GMT</pubDate>
<description>ST's new BrightSense image sensors ST's new BrightSense image sensors STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors VD55G4 and VD65G4 extend the ST BrightSense portfolio with compact, ultralow-power, microcontroller-compatible sensors for wearables, AR/VR, and smart devicesThese new global-shutter image sensors can consume up to 10x less, in operating mode at around 800×700 resolution and 10 frames per second Geneva, Swit</description>
</item>
<item>
<title>Astrazeneca Plc: Breztri approved in the US for asthma</title>
<link>https://6ix.com/company/astrazeneca-plc/news/breztri-approved-in-the-us-for-asthma</link>
<guid isPermaLink="true">https://6ix.com/company/astrazeneca-plc/news/breztri-approved-in-the-us-for-asthma</guid>
<pubDate>Tue, 28 Apr 2026 06:00:00 GMT</pubDate>
<description>AstraZeneca's Breztri Aerosphere has received US FDA approval for the maintenance treatment of asthma in patients aged 12 and older, marking its second indication beyond COPD. This single-inhaler triple therapy, combining budesonide, glycopyrrolate, and formoterol fumarate, demonstrated statistically significant and clinically meaningful improvements in lung function compared to dual ICS/LABA therapy in the Phase III KALOS and LOGOS trials. Breztri, previously approved for COPD in 2020 and presc</description>
</item>
<item>
<title>Barclays Plc: 1st Quarter Results</title>
<link>https://6ix.com/company/barclays-plc/news/1st-quarter-results-59</link>
<guid isPermaLink="true">https://6ix.com/company/barclays-plc/news/1st-quarter-results-59</guid>
<pubDate>Tue, 28 Apr 2026 06:00:00 GMT</pubDate>
<description>Barclays PLC reported a first-quarter 2026 return on tangible equity (RoTE) of 13.5%, with earnings per share (EPS) growing 8% to 14.1p, and announced a £500 million share buyback. Total income increased by 6% year-on-year to £8.2 billion, driven by a 6% rise in net interest income and strong performance in Global Markets, which generated over £4 billion in quarterly income for the first time. The cost-to-income ratio improved to 56%, and the Common Equity Tier 1 (CET1) ratio remained robust at </description>
</item>
<item>
<title>Advanced Micro Devices Inc: AMD Announces “Advancing AI 2026”</title>
<link>https://6ix.com/company/advanced-micro-devices-inc/news/amd-announces-advancing-ai-2026</link>
<guid isPermaLink="true">https://6ix.com/company/advanced-micro-devices-inc/news/amd-announces-advancing-ai-2026</guid>
<pubDate>Tue, 28 Apr 2026 04:00:00 GMT</pubDate>
<description>News Highlights: Advancing AI is AMD’s flagship global AI event, bringing developers, customers, enterprise leaders and partners together, showcasing the</description>
</item>
<item>
<title>Pepsico Inc: PepsiCo, Givaudan, Smurfit Westrock and Statkraft Sign 10‑Year Renewable Energy Agreement to Advance Value Chain Decarbonization Across Europe</title>
<link>https://6ix.com/company/pepsico-inc/news/pepsico-givaudan-smurfit-westrock-and-statkraft-sign-10year-renewable-energy-agreement-to-advance-value-chain-decarbonization-across-europe</link>
<guid isPermaLink="true">https://6ix.com/company/pepsico-inc/news/pepsico-givaudan-smurfit-westrock-and-statkraft-sign-10year-renewable-energy-agreement-to-advance-value-chain-decarbonization-across-europe</guid>
<pubDate>Tue, 28 Apr 2026 04:00:00 GMT</pubDate>
<description>PepsiCo, Givaudan, Statkraft and Smurfit Westrock announce a renewable energy initiative enabled by the pep+ REnew program, supported by Statkraft, to reduce</description>
</item>
<item>
<title>Honeywell International Inc: Honeywell Announces Board of Directors for Honeywell Aerospace</title>
<link>https://6ix.com/company/honeywell-international-inc/news/honeywell-announces-board-of-directors-for-honeywell-aerospace</link>
<guid isPermaLink="true">https://6ix.com/company/honeywell-international-inc/news/honeywell-announces-board-of-directors-for-honeywell-aerospace</guid>
<pubDate>Tue, 28 Apr 2026 04:00:00 GMT</pubDate>
<description>Directors bring compelling mix of aerospace and defense expertise, leadership experience, and financial and capital markets backgroundsHoneywell spin-off of</description>
</item>
<item>
<title>Oracle Corporation: Oracle, BorderPlex, and Bloom Energy to Power Project Jupiter with Cleaner, Water-Efficient Fuel Cell Technology</title>
<link>https://6ix.com/company/oracle-corporation/news/oracle-borderplex-and-bloom-energy-to-power-project-jupiter-with-cleaner-water-efficient-fuel-cell-technology</link>
<guid isPermaLink="true">https://6ix.com/company/oracle-corporation/news/oracle-borderplex-and-bloom-energy-to-power-project-jupiter-with-cleaner-water-efficient-fuel-cell-technology</guid>
<pubDate>Mon, 27 Apr 2026 20:05:00 GMT</pubDate>
<description>Oracle and BorderPlex Digital Assets today announced Project Jupiter will utilize Bloom Energy fuel cells to fully power the AI data center campus in Doña Ana County, New Mexico. As part of Oracle and Bloom's previously announced expanded partnership, the data center will be supported by up to 2.45 GW of installed Bloom fuel cell capacity. This updated power design will replace Project Jupiter's previously planned gas turbines and diesel generators and consolidate the facility into one single mi</description>
</item>
<item>
<title>Rambus Inc: Rambus Reports First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/rambus-inc/news/rambus-reports-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/rambus-inc/news/rambus-reports-first-quarter-2026-financial-results</guid>
<pubDate>Mon, 27 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 27, 2026--Rambus Inc. (NASDAQ:RMBS), a provider of industry-leading chips and IP making data faster and safer, today reported financial results for the first quarter ended March 31, 2026. GAAP revenue for the first quarter was $180.2 million, licensing billings were $70.8 million, product revenue was $88.0 million, and contract and other revenue was $22.6 million. The Company also generated $83.2 million in cash from operating activities in the first quarter.</description>
</item>
<item>
<title>Microsoft Corporation: Power Apps Adoption Outpaces Governance as Security and Compliance Risks Grow, Says Info-Tech Research Group</title>
<link>https://6ix.com/company/microsoft-corporation/news/power-apps-adoption-outpaces-governance-as-security-and-compliance-risks-grow-says-info-tech-research-group</link>
<guid isPermaLink="true">https://6ix.com/company/microsoft-corporation/news/power-apps-adoption-outpaces-governance-as-security-and-compliance-risks-grow-says-info-tech-research-group</guid>
<pubDate>Mon, 27 Apr 2026 19:48:00 GMT</pubDate>
<description>Although low-code/no-code (LCNC) platforms like Microsoft Power Apps make application development faster and more accessible for business users, enterprises that adopt them without strategy or governance may expose their organizations to potential security, compliance, and performance risks, according to new insights from Info-Tech Research Group. The firm's newly published blueprint, Develop a Plan to Overcome Your Microsoft Power Apps Challenges, provides a practical approach to help IT leader</description>
</item>
<item>
<title>Colgate-palmolive Company: Colgate-Palmolive Announces Webcast of its 2026 First Quarter Earnings Conference Call May 1, 2026 - Now at 8:00 a.m. ET and its 2026 Annual Meeting of Stockholders on May 8, 2026 at 10:00 a.m. ET</title>
<link>https://6ix.com/company/colgate-palmolive-company/news/colgate-palmolive-announces-webcast-of-its-2026-first-quarter-earnings-conference-call-may-1-2026-now-at-800-am-et-and-its-2026-annual-meeting-of-stockholders-on-may-8-2026-at-1000-am-et</link>
<guid isPermaLink="true">https://6ix.com/company/colgate-palmolive-company/news/colgate-palmolive-announces-webcast-of-its-2026-first-quarter-earnings-conference-call-may-1-2026-now-at-800-am-et-and-its-2026-annual-meeting-of-stockholders-on-may-8-2026-at-1000-am-et</guid>
<pubDate>Mon, 27 Apr 2026 19:44:00 GMT</pubDate>
<description>NEW YORK, April 27, 2026--Due to a scheduling conflict, Colgate-Palmolive Company (NYSE:CL) will now provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:00 a.m. ET (previously 8:30 a.m. ET). The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, Executive Vice President, Investor Relations, Claire Ross, and Executive Vice President, M&A and Special Projects, John Faucher. Investors may access</description>
</item>
<item>
<title>Merck & Company Inc: Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight</title>
<link>https://6ix.com/company/merck-and-company-inc/news/peripheral-t-cell-lymphoma-market-to-witness-significant-expansion-at-a-cagr-of-7percent-during-the-forecast-period-2026-2036-amid-advancing-treatment-landscape-or-delveinsight</link>
<guid isPermaLink="true">https://6ix.com/company/merck-and-company-inc/news/peripheral-t-cell-lymphoma-market-to-witness-significant-expansion-at-a-cagr-of-7percent-during-the-forecast-period-2026-2036-amid-advancing-treatment-landscape-or-delveinsight</guid>
<pubDate>Mon, 27 Apr 2026 17:00:00 GMT</pubDate>
<description>The peripheral T-cell lymphoma treatment market is witnessing steady growth, primarily driven by the increasing incidence, leading to an increased patient population, which fuels the ongoing treatment demand. Additionally, the launch of emerging therapies such as Duvelisib (COPIKTRA) (Secura Bio), Lacutamab (IPH4102) (Innate Pharma), Linperlisib (YY-20394/linprixetine) (Shanghai YingLi Pharmaceutical), KEYTRUDA (Merck), OPDIVO (BMS), Golidocitinib (AZD4205/DZD4205) (Dizal Pharmaceuticals), and o</description>
</item>
<item>
<title>Linde Plc Ordinary Shares: Linde Declares Dividend in Second Quarter 2026</title>
<link>https://6ix.com/company/linde-plc-ordinary-shares/news/linde-declares-dividend-in-second-quarter-2026</link>
<guid isPermaLink="true">https://6ix.com/company/linde-plc-ordinary-shares/news/linde-declares-dividend-in-second-quarter-2026</guid>
<pubDate>Mon, 27 Apr 2026 16:50:00 GMT</pubDate>
<description>WOKING, England, April 27, 2026--Linde plc (Nasdaq: LIN) announced its Board of Directors has declared a quarterly dividend of $1.60 per share.</description>
</item>
<item>
<title>Adobe Systems Incorporated: Personalization at Scale: 3,000 Custom Baseballs, One Unforgettable Adobe Summit</title>
<link>https://6ix.com/company/adobe-systems-incorporated/news/personalization-at-scale-3000-custom-baseballs-one-unforgettable-adobe-summit</link>
<guid isPermaLink="true">https://6ix.com/company/adobe-systems-incorporated/news/personalization-at-scale-3000-custom-baseballs-one-unforgettable-adobe-summit</guid>
<pubDate>Mon, 27 Apr 2026 16:02:00 GMT</pubDate>
<description>Demonstrating the tangible power of personalization at scale, Sunny Side Ink successfully executed a high-impact brand activation in collaboration with Adobe and MLB at Adobe Summit 2026 in Las Vegas. This initiative showcased the seamless integration of advanced content supply chains to deliver bespoke physical assets at an unprecedented volume, underscoring the company's technical precision and innovative approach to customer engagement.</description>
</item>
<item>
<title>Duke Energy Corporation: Duke Energy commits $1 million to strengthen nonprofits helping North Carolina customers meet essential needs</title>
<link>https://6ix.com/company/duke-energy-corporation/news/duke-energy-commits-dollar1-million-to-strengthen-nonprofits-helping-north-carolina-customers-meet-essential-needs</link>
<guid isPermaLink="true">https://6ix.com/company/duke-energy-corporation/news/duke-energy-commits-dollar1-million-to-strengthen-nonprofits-helping-north-carolina-customers-meet-essential-needs</guid>
<pubDate>Mon, 27 Apr 2026 14:13:00 GMT</pubDate>
<description>The Duke Energy Foundation is committing $1 million to support nonprofit organizations across North Carolina that deliver critical community services, including housing stability, food access, health care, utility assistance and more.</description>
</item>
<item>
<title>The Boeing Company: Boeing, U.S. Navy Achieve Successful MQ-25A Test Flight</title>
<link>https://6ix.com/company/the-boeing-company/news/boeing-us-navy-achieve-successful-mq-25a-test-flight</link>
<guid isPermaLink="true">https://6ix.com/company/the-boeing-company/news/boeing-us-navy-achieve-successful-mq-25a-test-flight</guid>
<pubDate>Mon, 27 Apr 2026 13:40:00 GMT</pubDate>
<description>Boeing [NYSE: BA] and the U.S. Navy have successfully completed the first test flight of an operational MQ-25A Stingray™. The milestone advances the Stingray closer to aircraft carrier operations and marks the beginning of a new era in naval aviation.</description>
</item>
<item>
<title>Gen Digital Inc.: Gen Brings Trusted Financial Intelligence to Microsoft's Copilot Discover Feeds</title>
<link>https://6ix.com/company/gen-digital-inc/news/gen-brings-trusted-financial-intelligence-to-microsofts-copilot-discover-feeds</link>
<guid isPermaLink="true">https://6ix.com/company/gen-digital-inc/news/gen-brings-trusted-financial-intelligence-to-microsofts-copilot-discover-feeds</guid>
<pubDate>Mon, 27 Apr 2026 13:00:00 GMT</pubDate>
<description>Gen (NASDAQ: GEN), a global company dedicated to powering Digital Freedom, announced today it is integrating Engine by Gen directly into Microsoft products like Copilot, MSN and Bing, bringing trusted, compliant financial information and relevant offers into AI-powered experiences across Microsoft. The integration helps provide easier access to trusted, personalized information that empowers users to make more confident financial decisions.</description>
</item>
<item>
<title>Walt Disney Company: Disney and Make-A-Wish Team Up to Grant Life-changing Wishes for Kids Around the World During "Disney Week of Wishes"</title>
<link>https://6ix.com/company/walt-disney-company/news/disney-and-make-a-wish-team-up-to-grant-life-changing-wishes-for-kids-around-the-world-during-disney-week-of-wishes</link>
<guid isPermaLink="true">https://6ix.com/company/walt-disney-company/news/disney-and-make-a-wish-team-up-to-grant-life-changing-wishes-for-kids-around-the-world-during-disney-week-of-wishes</guid>
<pubDate>Mon, 27 Apr 2026 13:00:00 GMT</pubDate>
<description>BURBANK, Calif., April 27, 2026--The Walt Disney Company (NYSE: DIS) today launched "Disney Week of Wishes," an annual celebration of its longstanding relationship with Make-A-Wish that harnesses the full power of Disney’s stories, characters, and experiences across the company to grant life-changing wishes for children around the globe.</description>
</item>
<item>
<title>Honeywell International Inc: HONEYWELL ANNOUNCES PARTICIPATION AT WOLFE RESEARCH GLOBAL TRANSPORTATION AND INDUSTRIALS CONFERENCE</title>
<link>https://6ix.com/company/honeywell-international-inc/news/honeywell-announces-participation-at-wolfe-research-global-transportation-and-industrials-conference</link>
<guid isPermaLink="true">https://6ix.com/company/honeywell-international-inc/news/honeywell-announces-participation-at-wolfe-research-global-transportation-and-industrials-conference</guid>
<pubDate>Mon, 27 Apr 2026 13:00:00 GMT</pubDate>
<description>Honeywell (NASDAQ: HON) today announced its participation at Wolfe Research's Global Transportation and Industrials Conference in New York City on Tuesday, May 19, 2026. Mike Stepniak, senior vice president and chief financial officer will present from 8:00 a.m. - 8:30 a.m. EDT.</description>
</item>
<item>
<title>Goldman Sachs Group Inc: Goldman Sachs Alternatives Announces Strategic Investment in Kashable, Leading the Company’s Series C Equity Round</title>
<link>https://6ix.com/company/goldman-sachs-group-inc/news/goldman-sachs-alternatives-announces-strategic-investment-in-kashable-leading-the-companys-series-c-equity-round</link>
<guid isPermaLink="true">https://6ix.com/company/goldman-sachs-group-inc/news/goldman-sachs-alternatives-announces-strategic-investment-in-kashable-leading-the-companys-series-c-equity-round</guid>
<pubDate>Mon, 27 Apr 2026 13:00:00 GMT</pubDate>
<description>GS Investment underscores shared commitment to expanding responsible financial access, advancing economic mobility, and scaling a high-performance financial wellness platform that delivers meaningful impact NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Kashable, a mission-driven fintech platform redefining credit for working Americans, today announced a $60 million Series C funding round, led by Sustainable Investing at Goldman Sachs Alternatives, with participation from existing investors Revolu</description>
</item>
<item>
<title>Halliburton Company: Greenland Energy (NASDAQ: GLND) Signs Halliburton Agreement for 2026 Jameson Land Drilling Campaign</title>
<link>https://6ix.com/company/halliburton-company/news/greenland-energy-nasdaq-glnd-signs-halliburton-agreement-for-2026-jameson-land-drilling-campaign</link>
<guid isPermaLink="true">https://6ix.com/company/halliburton-company/news/greenland-energy-nasdaq-glnd-signs-halliburton-agreement-for-2026-jameson-land-drilling-campaign</guid>
<pubDate>Mon, 27 Apr 2026 12:30:00 GMT</pubDate>
<description>Partnership Secures Advanced Well Technologies and Arctic Operating ExpertiseHOUSTON, April 27, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Energy Company (“Greenland”) (NASDAQ: GLND) today announced the signing of an agreement with Halliburton for integrated consulting services and logistical management relating to the planning, coordination, handling, and transportation of equipment, services, and goods. The agreement includes comprehensive well and drilling services for Greenland Energy’s o</description>
</item>
<item>
<title>Johnson & Johnson: FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)</title>
<link>https://6ix.com/company/johnson-and-johnson/news/fda-grants-priority-review-for-imaavyr-nipocalimab-aahu-as-the-potential-first-approved-treatment-for-people-living-with-warm-autoimmune-hemolytic-anemia-waiha</link>
<guid isPermaLink="true">https://6ix.com/company/johnson-and-johnson/news/fda-grants-priority-review-for-imaavyr-nipocalimab-aahu-as-the-potential-first-approved-treatment-for-people-living-with-warm-autoimmune-hemolytic-anemia-waiha</guid>
<pubDate>Mon, 27 Apr 2026 12:03:00 GMT</pubDate>
<description>Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY® (nipocalimab-aahu),c confirming the urgent need for treatment options in warm autoimmune hemolytic anemia (wAIHA). Priority Review is granted to medicines that may offer significant improvements in safety or effectiveness for serious conditions and shortens the FDA review timeline to approximately six month</description>
</item>
<item>
<title>Johnson & Johnson: FDA approves CAPLYTA® (lumateperone) sNDA with robust new data supporting reduced risk of relapse in schizophrenia</title>
<link>https://6ix.com/company/johnson-and-johnson/news/fda-approves-caplytar-lumateperone-snda-with-robust-new-data-supporting-reduced-risk-of-relapse-in-schizophrenia</link>
<guid isPermaLink="true">https://6ix.com/company/johnson-and-johnson/news/fda-approves-caplytar-lumateperone-snda-with-robust-new-data-supporting-reduced-risk-of-relapse-in-schizophrenia</guid>
<pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
<description>Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) based on long-term data evaluating the safety and efficacy of CAPLYTA® (lumateperone) for the prevention of relapse in schizophrenia. The data further reinforces the long-term efficacy and tolerability of CAPLYTA® as the latest addition to Johnson & Johnson's leading portfolio of neuropsychiatric therapies.</description>
</item>
<item>
<title>Microchip Technology Inc: Microchip Increases Manufacturing Capacity of its Hydrogen Masers</title>
<link>https://6ix.com/company/microchip-technology-inc/news/microchip-increases-manufacturing-capacity-of-its-hydrogen-masers</link>
<guid isPermaLink="true">https://6ix.com/company/microchip-technology-inc/news/microchip-increases-manufacturing-capacity-of-its-hydrogen-masers</guid>
<pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
<description>The company opened a new facility in Tuscaloosa, Ala., to increase production and reduce lead timesCHANDLER, Ariz., April 27, 2026 (GLOBE NEWSWIRE) -- A hydrogen maser is an atomic clock that uses properties of hydrogen atoms to emit precise microwave frequencies for highly stable and precise timekeeping. Hydrogen masers are deployed globally and actively contribute to Coordinated Universal Time (UTC), the global standard for the time of day, synchronizing critical applications such as power gri</description>
</item>
<item>
<title>Verizon Communications Inc: Verizon’s Transformation Actions Deliver Growth & Profitability in 1Q26; Company Raises Adjusted EPS Guidance</title>
<link>https://6ix.com/company/verizon-communications-inc/news/verizons-transformation-actions-deliver-growth-and-profitability-in-1q26-company-raises-adjusted-eps-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/verizon-communications-inc/news/verizons-transformation-actions-deliver-growth-and-profitability-in-1q26-company-raises-adjusted-eps-guidance</guid>
<pubDate>Mon, 27 Apr 2026 11:00:00 GMT</pubDate>
<description>Verizon Achieved First Positive 1Q Postpaid Phone Net Additions Since 2013, a Year-Over-Year Improvement of Over 340,000; Guidance Raised to Top Half of 750,000 - 1M RangeKey 1Q26 Highlights: Strong consolidated net income leading to highest quarterly Adjusted EBITDA1 in company historySolid earnings per share (EPS) growth, which drove highest quarterly Adjusted EPS1 growth since 2021Strong cash flow from operating activities providing confidence in free cash flow1 guidance NEW YORK, April 27, 2</description>
</item>
<item>
<title>United Airlines Holdings Inc: Statement from United Airlines CEO Scott Kirby</title>
<link>https://6ix.com/company/united-airlines-holdings-inc/news/statement-from-united-airlines-ceo-scott-kirby</link>
<guid isPermaLink="true">https://6ix.com/company/united-airlines-holdings-inc/news/statement-from-united-airlines-ceo-scott-kirby</guid>
<pubDate>Mon, 27 Apr 2026 11:00:00 GMT</pubDate>
<description>Over the last two weeks, there's been a lot of commentary about a potential merger between United Airlines and American Airlines. And to be direct, here's what happened: I approached American about exploring a combination because I thought we could do something incredible for customers together. I always knew that the only way any merger could be successful (and approved) is if it was great for customers and with a willing partner that shared my big, bold vision. I was confident that this combin</description>
</item>
<item>
<title>Eli Lilly And Company: Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera</title>
<link>https://6ix.com/company/eli-lilly-and-company/news/lilly-to-acquire-ajax-therapeutics-to-advance-outcomes-for-patients-with-myelofibrosis-and-polycythemia-vera</link>
<guid isPermaLink="true">https://6ix.com/company/eli-lilly-and-company/news/lilly-to-acquire-ajax-therapeutics-to-advance-outcomes-for-patients-with-myelofibrosis-and-polycythemia-vera</guid>
<pubDate>Mon, 27 Apr 2026 10:45:00 GMT</pubDate>
<description>Eli Lilly and Company (NYSE: LLY) and Ajax Therapeutics, Inc. ("Ajax"), a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), today announced a definitive agreement for Lilly to acquire Ajax. Ajax's lead asset, AJ1-11095, is an investigational, once-daily oral, first-in-class Type II JAK2 inhibitor currently being evaluated in a Phase 1 clinical trial, AJX-101, in patients with myelofibrosis who have previously been treated w</description>
</item>
<item>
<title>Viavi Solutions Inc: VIAVI Announces Investment in PCIe 7.0 Protocol Analysis Testing Platform</title>
<link>https://6ix.com/company/viavi-solutions-inc/news/viavi-announces-investment-in-pcie-70-protocol-analysis-testing-platform</link>
<guid isPermaLink="true">https://6ix.com/company/viavi-solutions-inc/news/viavi-announces-investment-in-pcie-70-protocol-analysis-testing-platform</guid>
<pubDate>Mon, 27 Apr 2026 10:30:00 GMT</pubDate>
<description>VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced investment in its new PCIe® 7.0 protocol analysis testing platform which will include analyzers, exercisers and high-performance interposers from the VIAVI Xgig® family. The Xgig PCIe 7.0 analysis chassis design will be showcased for the first time at the PCI-SIG® Developers Conference from May 6-7, 2026 at the Santa Clara Convention Center.</description>
</item>
<item>
<title>Nvidia Corporation: PATEO and NVIDIA Partner to Debut Pioneering Software-Hardware Integrated AI Box Solution</title>
<link>https://6ix.com/company/nvidia-corporation/news/pateo-and-nvidia-partner-to-debut-pioneering-software-hardware-integrated-ai-box-solution</link>
<guid isPermaLink="true">https://6ix.com/company/nvidia-corporation/news/pateo-and-nvidia-partner-to-debut-pioneering-software-hardware-integrated-ai-box-solution</guid>
<pubDate>Mon, 27 Apr 2026 10:29:00 GMT</pubDate>
<description>On April 23, PATEO reached a series of deep collaborations with NVIDIA and a leading New Energy Vehicle (NEV) OEM. The company is accelerating the transition of "on-vehicle large models" from technical verification to large-scale mass production, achieving substantial progress in the implementation of in-vehicle AI large models and the application of advanced computing power platforms.</description>
</item>
</channel>
</rss>